Skip to main content
Premium Trial:

Request an Annual Quote

Advertising to Support Free Access to Journals? The Audacity!

The New York Times has an article about Reed Elsevier's latest experiment -- a program to offer oncologists free access to 100 of its journals. "Elsevier hopes to sign up 150,000 professional users within the next 12 months and to attract advertising and sponsorships, especially from pharmaceutical companies with cancer drugs to sell," according to the story. GTO knows most of you aren't card-carrying oncologists, but isn't it nice to see that a publishing giant is trying to find ways to make open access viable?

And in a related post, Pharmboy has a post at Terra Sigillata about the impressive quality of bloggers who have agreed to write content on the Elsevier site.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.